Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients
Authors
Keywords
Cisplatin, Hypoxic tumors, Drug resistance, Chemosensitizers, Tumor oxygenation
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 162, Issue -, Pages 103327
Publisher
Elsevier BV
Online
2021-04-21
DOI
10.1016/j.critrevonc.2021.103327
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular Vesicles as Transmitters of Hypoxia Tolerance in Solid Cancers
- (2019) Marijke Zonneveld et al. Cancers
- Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin
- (2019) Caijun Dong et al. OncoTargets and Therapy
- HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity
- (2019) Basmina Parmakhtiar et al. MOLECULAR CANCER RESEARCH
- Circulating MicroRNAs in Cancer: Potential and Challenge
- (2019) Mengying Cui et al. Frontiers in Genetics
- Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
- (2019) Youngjin Han et al. ONCOGENE
- Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
- (2019) Devarajan Nalini et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions
- (2018) Elisabetta Gabano et al. DALTON TRANSACTIONS
- Scutellaria baicalensis targets the hypoxia-inducible factor-1α and enhances cisplatin efficacy in ovarian cancer
- (2018) Imran Hussain et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins
- (2018) Kalpana Deepa Priya Dorayappan et al. ONCOGENE
- The role of HIF-1α in chemo-/radioresistant tumors
- (2018) Yu Xia et al. OncoTargets and Therapy
- A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
- (2018) Eroje M. Ahmed et al. CELLULAR ONCOLOGY
- The hypoxic tumour microenvironment
- (2018) Varvara Petrova et al. Oncogenesis
- Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
- (2018) Christophe Deben et al. Cancers
- The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer
- (2018) Xiaoliang Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Role of HIF-1 in Cancer Progression: Novel Insights. A Review
- (2018) Aldo Pezzuto et al. CURRENT MOLECULAR MEDICINE
- Hypoxia-activated prodrugs and redox-responsive nanocarriers
- (2018) Yun Zeng et al. International Journal of Nanomedicine
- Phytochemicals: Current strategy to sensitize cancer cells to cisplatin
- (2018) Chao-Yue Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α
- (2017) Yue Pan et al. International Journal of Biological Sciences
- Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer
- (2017) Chang-Sheng Lin et al. International Journal of Medical Sciences
- Hypoxia/IL-1α axis promotes gastric cancer progression and drug resistance
- (2017) Yi Xuan et al. Journal of Digestive Diseases
- Pharmacological effects of asiatic acid in glioblastoma cells under hypoxia
- (2017) Flourina Kumar Thakor et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
- (2017) Xue Feng et al. OncoTargets and Therapy
- A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinoma
- (2017) Xiang Qi et al. Oncotarget
- MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer
- (2017) Giuseppina Roscigno et al. Oncotarget
- Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
- (2017) Ajimu Keremu et al. BIOSCIENCE REPORTS
- Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline—A study using zebrafish model
- (2016) Jhansi Rani Nathan et al. BIOMEDICINE & PHARMACOTHERAPY
- Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer
- (2016) Fuquan Zhang et al. CANCER SCIENCE
- Plant-Derived Agents for Counteracting Cisplatin-Induced Nephrotoxicity
- (2016) Shreesh Ojha et al. Oxidative Medicine and Cellular Longevity
- Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells
- (2016) Shrikant Pradhan et al. Oncotarget
- MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer
- (2016) Xiaoxiao Ge et al. Oncotarget
- Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
- (2016) Jhih-Pu Syu et al. Oncotarget
- Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms
- (2015) Guifang Yu et al. Cancer Cell International
- Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells
- (2015) Leli Zeng et al. CHEMISTRY-A EUROPEAN JOURNAL
- Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links
- (2015) Akshada Sawant et al. DNA REPAIR
- Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy
- (2015) MICHAL PASTOREK et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization
- (2015) Carina Fischer et al. Molecular Cancer
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- HIF-1 Signaling in Drug Resistance to Chemotherapy
- (2014) N.A. Warfel et al. CURRENT MEDICINAL CHEMISTRY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Survivin as a Preferential Target for Cancer Therapy
- (2014) Mahsa Mobahat et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis: A Gynecologic Oncology Group Study
- (2014) Paul A. DiSilvestro et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple functions of hypoxia-regulated miR-210 in cancer
- (2014) Qin Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Synergistic Inhibitory Effect of Hyperbaric Oxygen Combined with Sorafenib on Hepatoma Cells
- (2014) Hai-Shan Peng et al. PLoS One
- Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer
- (2014) Oscar Arrieta et al. RADIOTHERAPY AND ONCOLOGY
- Imaging Tumor Hypoxia to Advance Radiation Oncology
- (2013) Chen-Ting Lee et al. ANTIOXIDANTS & REDOX SIGNALING
- Targeting mitochondria by α-tocopheryl succinate overcomes hypoxia-mediated tumor cell resistance to treatment
- (2013) Andrey V. Kulikov et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer
- (2013) Xue-Pu Sun et al. FEBS Journal
- p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax
- (2013) CHAE WON KIM et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- An Overview of Cyclophilins in Human Cancers
- (2013) J Lee et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Hypoxia–Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha
- (2013) Jennifer Adamski et al. PLoS One
- Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer
- (2012) Hak-Su Kim et al. APOPTOSIS
- Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)
- (2012) Prabodh K Kandala et al. BMC Medicine
- Chemotherapeutic Sensitivity of Testicular Germ Cell Tumors Under Hypoxic Conditions Is Negatively Regulated by SENP1-Controlled Sumoylation of OCT4
- (2012) Y.-C. Wu et al. CANCER RESEARCH
- Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cellsin vivo
- (2012) Sutapa Sinha et al. INTERNATIONAL JOURNAL OF CANCER
- Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia
- (2012) Makoto Shimanishi et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Hypoxia-Inducible Factor-1α and Excision Repair Cross-Complementing 1 in Patients with Small Cell Lung Cancer Who Received Front-Line Platinum-Based Chemotherapy: A Retrospective Study
- (2012) Gyeong-Won Lee et al. Journal of Thoracic Oncology
- Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells
- (2012) LI JIANG et al. Molecular Medicine Reports
- Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4
- (2011) Saskia E Rademakers et al. BMC CANCER
- Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans
- (2011) Yeonghwan Kim et al. HEPATOLOGY
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Novel combinational treatment of cisplatin with cyclophilin a inhibitors in human heptocellular carcinomas
- (2010) Jinhwa Lee ARCHIVES OF PHARMACAL RESEARCH
- Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: The mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1
- (2010) Xin-zhi Huang et al. CANCER BIOLOGY & THERAPY
- Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
- (2010) Danny Rischin et al. JOURNAL OF CLINICAL ONCOLOGY
- An Akt/Hypoxia-Inducible Factor-1 /Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells
- (2009) C. K. Lau et al. CLINICAL CANCER RESEARCH
- Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model
- (2009) S. L. C. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells
- (2008) J Hao et al. CANCER GENE THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More